Business Description
Hyperion DeFi Inc., formerly known as Eyenovia Inc., is a New York-based eye care company that develops and sells drug delivery technologies for treating eye conditions. Its main product, Optejet, is a platform designed to apply eye medication more precisely and effectively than traditional methods. The company holds several partnerships with pharmaceutical firms across the United States, Canada, China, South Korea, and Japan to bring a range of eye treatments to market. Founded in 2014, Hyperion DeFi continues to expand its portfolio through licensing and co-development agreements with global healthcare partners.
